Milliman - Capital Group Hedged U.S. Growth Fund BMRN Holdings History
Milliman - Capital Group Hedged U.S. Growth Fund's BioMarin Pharmaceutical Inc Holding Summary
As of 2025-03-31, Milliman - Capital Group Hedged U.S. Growth Fund held - shares of BioMarin Pharmaceutical Inc(BMRN), totaling N/A. This investment constitutes 0% of their stock portfolio, and Milliman - Capital Group Hedged U.S. Growth Fund now holds 0% of the outstanding BioMarin Pharmaceutical Inc(BMRN) stock.
The initial trade took place in 2023Q1. And since then Milliman - Capital Group Hedged U.S. Growth Fund has made 1 purchases of BMRN, at an average price of $102.79, for a total of 467.00 shares. In addition, there have been 7 sales at an average price of $74.16 for 467.00 shares. Based on historical transaction data and BMRN's current price of $57.50, Milliman - Capital Group Hedged U.S. Growth Fund's estimated gain on his BMRN holdings is $-13,371.74, reflecting a -27.86% gain to date.
Milliman - Capital Group Hedged U.S. Growth Fund BMRN ($57.50) Holding Chart
Milliman - Capital Group Hedged U.S. Growth Fund BMRN ($57.50) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
